SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Lundmark Joens)
 

Search: WFRF:(Lundmark Joens) > (2012) > Safety, tolerabilit...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study.

Winblad, Bengt (author)
Karolinska Institutet
Andreasen, Niels (author)
Karolinska Institutet
Minthon, Lennart (author)
Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups
show more...
Floesser, Annette (author)
Imbert, Georges (author)
Dumortier, Thomas (author)
Maguire, R Paul (author)
Blennow, Kaj, 1958 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Lundmark, Joens (author)
Staufenbiel, Matthias (author)
Orgogozo, Jean-Marc (author)
Graf, Ana (author)
show less...
 (creator_code:org_t)
2012
2012
English.
In: Lancet neurology. - 1474-4465. ; 11:7, s. 597-604
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Immunotherapy targeting the amyloid β (Aβ) peptide is a potential strategy to slow the progression of Alzheimer's disease. We aimed to assess the safety and tolerability of CAD106, a novel active Aβ immunotherapy for patients with Alzheimer's disease, designed to induce N-terminal Aβ-specific antibodies without an Aβ-specific T-cell response.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Keyword

Aged
Aged
80 and over
Alzheimer Disease
blood
drug therapy
immunology
Amyloid beta-Peptides
immunology
Antibody Formation
drug effects
Biological Markers
blood
Double-Blind Method
Female
Humans
Immunoglobulin G
blood
Immunotherapy
Male
Middle Aged
Treatment Outcome

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view